Mitigating the spread of a virus as infectious as SARS-CoV-2, the virus which causes COVID-19, requires having ample and accurate diagnostic tests available. However, in the United States community transmission began to occur before adequate testing measures could be implemented.
All articles by Utsav Aiya, MD
AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.
The promotion of arrhythmias in myocytes by mesenchymal stromal cells isolated from failing human hearts, which were found to produce high levels of interleukin-6 (IL-6), was abated in the presence of anti-IL-6 monoclonal antibodies.
Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.